Abstract
CD34 has long been defined as a canonical marker for endothelial progenitors as well as hematopoietic stem cells, implicating its role in vascular development and hematopoiesis. However, the precise developmental hierarchy and lineage potential of CD34+ cells remain controversial. In this study, we integrated inducible genetic lineage tracing techniques, proteomics and single-cell RNA-seq (scRNA-seq) analyses to elucidate the dynamic developmental trajectory of CD34+ cells during various embryonic periods in both humans and mice. Remarkably, our analyses indicated that the progeny of CD34+ cells marked distinct, spatiotemporally restricted progenitor waves with divergent fates, at which point cells adopted endothelial, hematopoietic and fibroblastic fates, respectively. During gastrulation (E6.5–E8.5), an initial wave of CD34+ progenitors predominantly orchestrates vasculogenesis via a Kdr-dependent mechanism. Subsequently, from E9.5 to E14.5, cell cycle activation serves as a molecular switch, facilitating the endothelial-to-hematopoietic transition (EHT) of CD34+ progenitors. Unexpectedly, we identify a wave of CD34+ progenitors in late embryogenesis that gives rise to fibroblasts, distinct from earlier endothelial or hematopoietic lineages. Furthermore, because umbilical cord blood is a valuable source of different circulating stem/progenitor cells, we distinguish circulating endothelial progenitors from fibroblast progenitors in human cord blood by unique molecular signatures, with GFPT2 specifically marking the fibroblast progenitors. Collectively, our study provides a high-resolution spatiotemporal atlas of CD34+ cells during embryogenesis, redefining the temporal shifts of CD34+ cells in cell states and offering a precise framework for manipulating CD34+ cells in regenerative medicine.

This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout







Similar content being viewed by others
Data availability
The publicly available datasets are provided in the supplementary material. Single-cell RNA-sequencing data generated in this study will be publicly accessible from the NCBI Gene Expression Omnibus (GSE317390). The human sequence data reported in this article are available in the Genome Sequence Archive in the National Genomics Data Center, China National Center for Bioinformation/Beijing Institute of Genomics, Chinese Academy of Sciences (HRA016338). Any additional information reported in this paper is available upon reasonable request.
References
Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221–8.
Wu H, Yang X, Chen T, Yu B, Chen M, Wang T, et al. Aneurysm is restricted by CD34+ cell-formed fibrous collars through the PDGFRb-PI3K Axis. Adv Sci. 2025;12:e2408996.
Jiang L, Chen T, Sun S, Wang R, Deng J, Lyu L, et al. Non-bone marrow CD34 + cells are crucial for endothelial repair of injured arteries. Circ Res. 2021;129:e146–e165.
Krause D, Ito T, Fackler M, Smith O, Collector M, Sharkis S, et al. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood. 1994;84:691–701.
Sidney LE, Branch MJ, Dunphy SE, Dua HS, Hopkinson A. Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells. 2014;32:1380–9.
Brown J, Greaves MF, Molgaard HV. The gene encoding the stem cell antigen, CD34, is conserved in mouse and expressed in haemopoietic progenitor cell lines, brain, and embryonic fibroblasts. Int Immunol. 1991;3:175–84.
Kojima Y, Tam OH, Tam PPL. Timing of developmental events in the early mouse embryo. Semin Cell Dev Biol. 2014;34:65–75.
Tam PPL, Loebel DAF. Gene function in mouse embryogenesis: get set for gastrulation. Nat Rev Genet. 2007;8:368–81.
DeLaughter DM, Bick AG, Wakimoto H, McKean D, Gorham JM, Kathiriya IS, et al. Single-cell resolution of temporal gene expression during heart development. Dev Cell. 2016;39:480–90.
Cao J, Spielmann M, Qiu X, Huang X, Ibrahim DM, Hill AJ, et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature. 2019;566:496–502.
Wood HB, May G, Healy L, Enver T, Morriss-Kay GM. CD34 expression patterns during early mouse development are related to modes of blood vessel formation and reveal additional sites of hematopoiesis. Blood. 1997;90:2300–11.
The International Mouse Phenotyping Consortium, Dickinson ME, Flenniken AM, Ji X, Teboul L, Wong MD, et al. High-throughput discovery of novel developmental phenotypes. Nature. 2016;537:508–14.
Kingsley PD, Malik J, Fantauzzo KA, Palis J. Yolk sac–derived primitive erythroblasts enucleate during mammalian embryogenesis. Blood. 2004;104:19–25.
Maltsev VA, Wobus AM, Rohwedel J, Bader M, Hescheler J. Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ Res. 1994;75:233–44.
Coscia F, Lengyel E, Duraiswamy J, Ashcroft B, Bassani-Sternberg M, Wierer M, et al. Multi-level proteomics identifies CT45 as a chemosensitivity mediator and immunotherapy target in ovarian cancer. Cell. 2018;175:159–170.e16.
Krinidis S, Chatzis V. A robust fuzzy local information C-Means clustering algorithm. IEEE Trans Image Process. 2010;19:1328–37.
Bezdek JC, Ehrlich R, Full W. FCM: The fuzzy c-means clustering algorithm. Comput Geosci. 1984;10:191–203.
Chan MM, Smith ZD, Grosswendt S, Kretzmer H, Norman TM, Adamson B, et al. Molecular recording of mammalian embryogenesis. Nature. 2019;570:77–82.
Dong J, Hu Y, Fan X, Wu X, Mao Y, Hu B, et al. Single-cell RNA-seq analysis unveils a prevalent epithelial/mesenchymal hybrid state during mouse organogenesis. Genome Biol. 2018;19:31.
Ren H, Zhou X, Yang J, Kou K, Chen T, Pu Z, et al. Single-cell RNA sequencing of murine hearts for studying the development of the cardiac conduction system. Sci Data. 2023;10:577.
Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 1995;376:62–6.
Susaki EA, Tainaka K, Perrin D, Kishino F, Tawara T, Watanabe TM, et al. Whole-brain imaging with single-cell resolution using chemical cocktails and computational analysis. Cell. 2014;157:726–39.
Lazarov T, Loyher PL, Yang H, Choo ZN, Deng Z, Nowotschin S, et al. Characterization of the mammalian prodefinitive angio-hematopoietic lineage. Sci Immunol. 2025;10:eadt6616.
Kobayashi M, Wei H, Yamanashi T, Azevedo Portilho N, Cornelius S, Valiente N, et al. HSC-independent definitive hematopoiesis persists into adult life. Cell Rep. 2023;42:112239.
Komorowska K, Doyle A, Wahlestedt M, Subramaniam A, Debnath S, Chen J, et al. Hepatic leukemia factor maintains quiescence of hematopoietic stem cells and protects the stem cell pool during regeneration. Cell Rep. 2017;21:3514–23.
Zhou F, Li X, Wang W, Zhu P, Zhou J, He W, et al. Tracing haematopoietic stem cell formation at single-cell resolution. Nature. 2016;533:487–92.
Iwasaki H, Arai F, Kubota Y, Dahl M, Suda T. Endothelial protein C receptor-expressing hematopoietic stem cells reside in the perisinusoidal niche in fetal liver. Blood. 2010;116:544–53.
Benz C, Copley MR, Kent DG, Wohrer S, Cortes A, Aghaeepour N, et al. Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs. Cell Stem Cell. 2012;10:273–83.
Ivanovs A, Rybtsov S, Anderson RA, Turner ML, Medvinsky A. Identification of the niche and phenotype of the first human hematopoietic stem cells. Stem Cell Rep. 2014;2:449–56.
Wang Y, Yao F, Wang L, Li Z, Ren Z, Li D, et al. Single-cell analysis of murine fibroblasts identifies neonatal to adult switching that regulates cardiomyocyte maturation. Nat Commun. 2020;11:2585.
Zhang W, Bouchard G, Yu A, Shafiq M, Jamali M, Shrager JB, et al. GFPT2 -expressing cancer-associated fibroblasts mediate metabolic reprogramming in human lung adenocarcinoma. Cancer Res. 2018;78:3445–57.
Wang L, Yang Y, Ma H, Xie Y, Xu J, Near D, et al. Single-cell dual-omics reveals the transcriptomic and epigenomic diversity of cardiac non-myocytes. Cardiovasc Res. 2021;118:1548–63.
Sun X, Wang T, Gong H, Qiu Y, Zhang Y, Chen M, et al. Circulating CD34+ fibroblast progenitors engaged in heart fibrosis of the allograft. Circ Res. 2026;138:e326558.
Rosa FF, Pires CF, Kurochkin I, Ferreira AG, Gomes AM, Palma LG, et al. Direct reprogramming of fibroblasts into antigen-presenting dendritic cells. Sci Immunol. 2018;3:eaau4292.
Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol. 1984;133:157–65.
Young P, Baumhueter S, Lasky L. The sialomucin CD34 is expressed on hematopoietic cells and blood vessels during murine development. Blood. 1995;85:96–105.
Joe AWB, Yi L, Natarajan A, Le Grand F, So L, Wang J, et al. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol. 2010;12:153–63.
Shalaby F, Ho J, Stanford WL, Fischer KD, Schuh AC, Schwartz L, et al. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell. 1997;89:981–90.
Zhu Q, Gao P, Tober J, Bennett L, Chen C, Uzun Y, et al. Developmental trajectory of prehematopoietic stem cell formation from endothelium. Blood. 2020;136:845–56.
Fennie C, Cheng J, Dowbenko D, Young P, Lasky L. CD34+ endothelial cell lines derived from murine yolk sac induce the proliferation and differentiation of yolk sac CD34+ hematopoietic progenitors. Blood. 1995;86:4454–67.
Dzierzak E. The emergence of definitive hematopoietic stem cells in the mammal. Curr Opin Hematol. 2005;12:197–202.
Du L, Sun X, Gong H, Wang T, Jiang L, Huang C, et al. Single-cell and lineage tracing studies reveal the impact of CD34+ cells on myocardial fibrosis during heart failure. Stem Cell Res Ther. 2023;14:33.
Xie J, Jiang L, Wang J, Yin Y, Wang R, Du L, et al. Multilineage contribution of CD34+ cells in cardiac remodeling after ischemia/reperfusion injury. Basic Res Cardiol. 2023;118:17.
Pu X, Zhu P, Zhou X, He Y, Wu H, Du L, et al. CD34+ cell atlas of main organs implicates its impact on fibrosis. Cell Mol Life Sci. 2022;79:576.
Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–6.
Chen T, Sun X, Gong H, Chen M, Li Y, Wang T, et al. Host CD34+ cells are replacing donor endothelium of transplanted heart. J Heart Lung Transpl. 2023;42:1651–65.
Rotmans JI, Heyligers JMM, Verhagen HJM, Velema E, Nagtegaal MM, de Kleijn DPV, et al. In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation. 2005;112:12–8.
Aoki J, Serruys PW, van Beusekom H, Ong ATL, McFadden EP, Sianos G, et al. Endothelial progenitor cell capture by stents coated with an antibody against CD34. J Am Coll Cardiol. 2005;45:1574–9.
Otis EM, Brent R. Equivalent ages in mouse and human embryos. Anat Rec. 1954;120:33–63.
Acknowledgements
The authors thank Dr. Yanhua Hu for the significant contribution to the construction of laboratory animal models. The authors are grateful to pathologists Buyi Zhang and Fei Hu at the Second Affiliated Hospital, Zhejiang University School of Medicine, for technical assistance in human embryo sample collection and preparation. We thank the technical assistant of Oebiotech Company, Novogene, Ribobio and Pioneer in Proteomics Biolabs. We thank Yuanyuan Lyu and Yun Lyu from the core facilities, Zhejiang University School of Medicine, for their technical support.
Funding
This study is in part supported by the National Natural Science Foundation of China W2541023 (QBX), U24A20799 (WM), 31830039 (QBX), 82400490 (SSS), 82400575 (KC), 82200479 (LJJ); National Key Research and Development Program 2023YFC3606201 (WM), Central guidance for local scientific and technological development funding projects 2024ZY01016 (WM), “Pioneer” and “Leading Goose” R&D Program of Zhejiang 2025C02147 (WM), Natural Science Foundation of Zhejiang Province LMS25H020009 (HG), The Fundamental Research Funds for the Central Universities 226-2025-00184 (KC).
Author information
Authors and Affiliations
Contributions
Conceptualization: QBX, TW, and HG. Methodology: TW, GGY, RHC, and MTY. Visualization: GGY and SSS. Supervision: HG, GGY, RHC, KC, WM, and QBX. Writing—original draft: TW and QBX. Writing—review and editing: TW, HG, GGY, RHC, SSS, XYH, BHZ, LJJ, YSZ, TTC, YQP, JHX, MJ, KC, WM, and QBX.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, T., Gong, H., Ye, G. et al. Multiple pathways of CD34+ cell differentiation during embryogenesis. Cell Death Differ (2026). https://doi.org/10.1038/s41418-026-01735-4
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41418-026-01735-4


